Biogen Pharmachem Industries Ltd

NSE: BSE: 531752

₹0.54

(0%)

Sat, 21 Mar 2026, 01:52 pm

MTF 5xInvest in Biogen Pharmachem Industries Ltd with 5x Leverage Buy with MTF

Market Cap487.41M

PE Ratio16.56

Dividend0

Finance

Investment Banks/Brokers

24.5K

Biogen Pharmachem Industries News

Biogen Pharmachem Board to Consider Bonus Shares

Biogen Pharmachem Industries Limited has scheduled a board meeting for March 23, 2026, to consider declaring bonus shares, subject to shareholder approval under SEBI regulations.

24 Feb 2026

co actions results

Biogen Pharmachem Board Meet Set for Feb 3, 2026

Biogen Pharmachem Industries Limited has scheduled a board meeting on February 3, 2026, to consider and approve Q3FY26 unaudited financial results for the quarter and nine months ended December 31, 2025.

19 Jan 2026

stocks

Biogen Pharmachem Submits Q3FY26 SEBI Certificate

Biogen Pharmachem Industries Limited submitted its quarterly certificate under SEBI Regulation 74(5) for Q3FY26 ended December 31, 2025, with no physical shares received for dematerialization during the quarter.

05 Jan 2026

stocks

Biogen Pharmachem Industries Reports Quarterly Financial Results for September 2025

Biogen Pharmachem Industries Limited announced its unaudited financial results for the quarter and half year ended September 30, 2025. The company reported total income of Rs 1.58 lakh and net profit after tax of Rs 0.85 lakh for the quarter. For the half year period, total income was Rs 1.44 lakh with net profit after tax of Rs 0.92 lakh. The company's equity share capital stands at Rs 90.26 crore. The board meeting was held on November 7, 2025, where directors approved the financial results. The company operates in a single business segment and has its registered office in Rajkot. The financial results were reviewed by statutory auditors who conducted a limited review of the statements.

07 Nov 2025

earnings

Biogen Pharmachem Industries Reports Turnaround with Rs 134.48 Lakh Net Profit in Q1

Biogen Pharmachem Industries Limited reported a net profit of Rs 134.48 lakhs for the quarter ended June 30, 2025, marking a significant turnaround from a loss of Rs 15.83 lakhs in the same quarter last year. The company's revenue from operations increased to Rs 154.28 lakhs compared to negative Rs 9.09 lakhs in the previous year quarter. Total expenses rose to Rs 19.80 lakhs from Rs 6.73 lakhs, primarily due to higher employee benefit expenses and other expenses. The company's paid-up equity share capital increased to Rs 9,026.03 lakhs from Rs 6,526.03 lakhs. Basic and diluted earnings per share stood at Rs 0.01. The Board of Directors approved these unaudited financial results in their meeting held on July 23, 2025.

23 Jul 2025

earnings

Showing 1–5 of 5

Rows per page:

Market Current News

Dow Jones Falls 414.97 Points in Trading Session

The Dow Jones Industrial Average unofficially closed down 414.97 points or 0.90 percent at 45,606.46 in the latest trading session, marking a notable decline for the benchmark index.

20 Mar 2026

global

NASDAQ Plunges 2.04% to Close at 21,639.13

The NASDAQ composite index suffered a significant decline, falling 451.56 points or 2.04% to close at 21,639.13 in the latest trading session.

20 Mar 2026

global

S&P 500 Falls 1.51% to Close at 6,506.52

The S&P 500 index unofficially closed down 99.97 points or 1.51 percent at 6,506.52, marking a notable decline in the benchmark U.S. stock market index.

20 Mar 2026

global

Trump Rejects Iran Ceasefire Possibility

Trump has publicly stated his lack of interest in pursuing a ceasefire agreement with Iran, marking a clear diplomatic stance on US-Iran relations.

20 Mar 2026

global

Trump Links Israel-Iran Conflict Resolution to U.S. Decision

Trump states that Israel will end its conflict with Iran when the United States chooses to end it, suggesting American influence over the regional dispute's resolution.

20 Mar 2026

global

Showing 1–5 of 92279

Rows per page:

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800